PHARMACYTE BIOTECH INC (PMCB)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.49-0.98%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · PMCB
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Total Revenues | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Cost of Revenues | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross Profit | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.7 | 0.9 | 0.3 | 0.5 | 2.0 | 1.2 | 1.4 | 3.5 | — | — | — |
| Other Operating Expenses, Total | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | (0.0) |
| Operating Income | (6.9) | (6.9) | (4.4) | (8.5) | (6.5) | (4.4) | (3.6) | (3.8) | (4.1) | (7.0) | (4.4) | (6.1) | (13.3) | (19.0) | (1.7) | — |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 |
| Other Non-Operating Income / Expenses | (12.6) | (12.6) | 35.0 | 8.9 | 2.1 | 0.2 | 0.1 | — | — | — | — | — | — | — | 0.1 | — |
| Income Tax Expense | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | (19.4) | (19.4) | 30.7 | 0.3 | (4.3) | (4.2) | (3.6) | (3.8) | (4.1) | (6.8) | (4.4) | (6.1) | (9.9) | (27.3) | (1.6) | (1.9) |
| Per Share | ||||||||||||||||
| Basic EPS | — | (2.77) | 3.19 | (1.80) | (0.22) | (0.27) | (2.45) | — | — | — | — | — | — | (0.05) | 0.00 | (0.01) |
| Diluted EPS | — | (2.77) | 3.19 | (1.80) | (0.22) | (0.27) | (2.45) | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | — | 8.4 | 7.3 | 9.6 | 19.5 | 15.5 | 1.4 | 0.9 | 1,100.1 | 968.6 | 845.3 | 752.4 | 704.3 | 583.2 | 441.0 | 374.8 |
| Diluted Weighted Avg Shares | — | 8.4 | 7.3 | 9.6 | 19.5 | 15.5 | 1.4 | 0.9 | 1,100.1 | 968.6 | 845.3 | 752.4 | 704.3 | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | (1.7) | — |
| EBIT | (6.9) | (6.9) | (4.4) | (8.5) | (6.5) | (4.4) | (3.6) | (3.8) | (4.1) | (7.0) | (4.4) | (6.1) | (13.3) | (19.0) | (1.7) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.